Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser

Neurology

Volumn 75, Issue 6, 2010, Pages 532-538

  Yang, N C C ^a   Lee, M J ^a,b   Chao, C C ^b   Chuang, Y T ^b   Lin, W M ^b   Chang, M F ^a   Hsieh, P C ^a   Kan, H W ^a   Lin, Y H ^b   Yang, C C ^b   Chiu, M J ^b   Liou, H H ^a,b   Hsieh, S T ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; PREALBUMIN; SERINE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DENERVATION; DISEASE COURSE; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MOTOR DYSFUNCTION; NERVE FIBER; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSORY DYSFUNCTION; SKIN BIOPSY; SKIN DENERVATION; AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHIES; AMYLOID NEUROPATHIES, FAMILIAL; GENETICS; INNERVATION; MIDDLE AGED; MISSENSE MUTATION; PATHOLOGY; SKIN;

AGED; ALANINE; AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHIES; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PREALBUMIN; SERINE; SKIN;

EID: 77955442857     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ec7fda     Document Type: Article

References (40)

1. Koike H, Misu K, Sugiura M, et al. Pathology of early-vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004;63:129-138.
2. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62: 1057-1062.
3. Misu Ki, Hattori N, Nagamatsu M, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan: clinicopathological and genetic features. Brain 1999;122:1951-1962.
4. Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849-856.
5. Zanette G, Cacciatori C, Tamburin S. Central sensitiza-tion in carpal tunnel syndrome with extraterritorial spread of sensory symptoms. Pain 2010;148:227-236.
6. Reilly M. Hereditary amyloid neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy, 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:1921-1936.
7. Thomas PK, King RHM. Peripheral nerve changes in amyloid neuropathy. Brain 1974;97:395-406.
8. Sousa MM, Saraiva MJ. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 2003;71:385-400.
9. Plante-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneu-ropathy (TTR-FAP). Neurology 2007;69:693-698.
10. Liu YT, Lee YC, Yang CC, Chen ML, Lin KP. Transthy-retin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression. J Neurol Sci 2008;267:91-99.
11. Hou X, Aguilar MI, Small DH. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FASEB J 2007;274:1637-1650.
12. Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123:1495-1504.
13. Kennedy WR, Said G. Sensory nerves in skin: answers about painful feet? Neurology 1999;53:1614-1615.
14. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol 2009;65:629-638.
15. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003;348:1243-1255.
16. Ebenezer GJ, McArthur JC, Thomas D, et al. Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain 2007;130: 2703-2714.
17. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropa-thology. Brain 2008;131:1912-1925.
18. Gibbons CH, Griffin JW, Polydefkis M, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006;66:256-258.
19. Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999;53:1634-1640.
20. Ebenezer GJ, Hauer P, Gibbons C, McArthur JC, Poly-defkis M. Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol 2007;66:1059-1073.
21. Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004;127:1593-1605.
22. Quattrini C, Jeziorska M, Boulton AJM, Malik RA. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 2008;31:140-145.
23. Tseng MT, Hsieh SC, Shun CT, et al. Skin denervation and cutaneous vasculitis in systemic lupus erythematosus. Brain 2006;129:977-985.
24. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations. Brain 2003;126:386-397.
25. Hsieh ST, Chiang HY, Lin WM. Pathology of nerve terminal degeneration in the skin. J Neuropathol Exp Neurol 2000;59:297-307.
26. Hsieh YL, Chiang H, Tseng TJ, Hsieh ST. Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy. J Neuropathol Exp Neurol 2008;67:93-104.
27. Kim DH, Zeldenrust SR, Low PA, Dyck PJ. Quantitative sensation and autonomic test abnormalities in transthyre-tin amyloidosis polyneuropathy. Muscle Nerve 2009;40: 363-370.
28. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007; 36:411-423.
29. Sebastiao MP, Lamzin V, Saraiva MJ, Damas AM. Transthy-retin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J Mol Biol 2001;306:733-744.
30. Cardoso I, Brito M, Saraiva MJ. Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related. Dis Markers 2008;25:37-47.
31. Santos SD, Magalhaes J, Saraiva MJ. Activation of the heat shock response in familial amyloidotic polyneuropathy. J Neuropathol Exp Neurol 2008;67:449-455.
32. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-1048.
33. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004;127: 1606-1615.
34. Boucek P, Havrdova T, Voska L, et al. Epidermal innerva-tion in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. Diabetes Care 2008;31:1611-1612.
35. Omdal R, Mellgren SI, Goransson L, et al. Small nerve fiber involvement in systemic lupus erythematosus: a controlled study. Arthritis Rheum 2002;46:1228-1232.
36. Goransson LG, Brun JG, Harboe E, Mellgren SI, Omdal R. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch Neurol 2006;63:1410-1413.
37. Goransson LG, Tjensvoll AB, Herigstad A, Mellgren SI, Omdal R. Small-diameter nerve fiber neuropathy in systemic lupus erythematosus. Arch Neurol 2006;63:401-404.
38. Chao CC, Hsieh ST, Shun CT, Hsieh SC. Skin denerva-tion and cutaneous vasculitis in eosinophilia-associated neuropathy. Arch Neurol 2007;64:959-965.
39. Hadden RDM, Hughes RAC. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry 2003; 74:ii9-ii14.
40. Thompson EJ. Different blood-CSF barriers. In: Thompson EJ, ed. Proteins of the Cerebrospinal Fluid: Analysis and Interpretation in the Diagnosis and Treatment of Neurological Disease, 2nd ed. Amsterdam: Elsevier; 2005:43-63.